RecruitingNot ApplicableNCT06074666

Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3


Sponsor

Roswell Park Cancer Institute

Enrollment

100 participants

Start Date

Nov 7, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The current study will assess the acceptability and feasibility of the CareMeds intervention with a larger sample (N = 100) across multiple sites in Buffalo, NY, and Atlanta, GA.


Eligibility

Min Age: 3 YearsMax Age: 9 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether teaching parents better behavioral skills helps their children take oral cancer medications more reliably. It focuses on parents of children (ages 3–9) being treated for acute lymphoblastic leukemia (ALL), a type of blood cancer. **You may be eligible if...** - You are the parent or primary caregiver responsible for giving your child their medication - Your child has been diagnosed with any type of acute lymphoblastic leukemia (ALL) - Your child is between 3 and 9 years old - Your child's treatment includes daily oral (by mouth) anti-cancer medication taken at home **You may NOT be eligible if...** - Your child is outside the 3–9 age range - Your child is not currently on oral at-home cancer medication - You are not the primary person responsible for giving your child their medications Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALCareMeds Intervention

3 parenting sessions will be offered during weeks 2 through 4 of the study period.

BEHAVIORALUsual Care Group

3 parenting sessions will be offered during weeks 13 through 15 of the study period.


Locations(1)

Roswell Park Comprehensive Cancer Center

Buffalo, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06074666


Related Trials